November 3, 2017 β A ten-year decline in the blood cholesterol of heart attack patients in Malaysia suggests statins are ...
Pharmaceuticals
This channel includes news and new technology innovations for cardiovascular pharmaceutics. This includes antiplatelet agents, anticoagulation drugs, INR testing, NOAC, OAC, IV administered drugs such as Heprin, and dual antiplatelet therapy.
November 1, 2017 β OrbusNeich reported results from the REDUCE trial in the Late-Breaking Clinical Trial session at the ...
October 27, 2017 β CeloNova BioSciences Inc. announced the U.S. Food and Drug Administration (FDA) approved expansion of ...
October 24, 2017 β Roche and Ncardia have reached a broad licensing agreement whereby Roche and its affiliate companies ...
October 18, 2017 β Results from the pivotal Phase 3 COMPASS study found that the Xarelto vascular dose plus aspirin 100 ...
October 4, 2017 β MyoKardia Inc. recently provided a clinical update on its MYK-491 program for dilated cardiomyopathy.
...
September 19, 2017 β The heart failure space across the seven key markets of the U.S., France, Germany, Italy, Spain ...
September 12, 2017 β Inclisiran lowers low-density lipoprotein (LDL, or βbadβ) cholesterol for up to one year in ...
September 12, 2017 β Very aggressive reduction of LDL-cholesterol to ultra-low levels was associated with progressively ...
September 12, 2017 β The IL-1Ξ² inhibitor canakinumab lowers the risk of cardiovascular disease and lung cancer risk by ...
September 12, 2017 β Rivaroxaban plus aspirin improves survival and reduces stroke and heart attack in patients with ...
September 11, 2017 β Merck and researchers in the Clinical Trial Service Unit at the University of Oxford announced the ...
September 1, 2017 β Apixaban lowers the risk of stroke compared to warfarin in anticoagulation-naΓ―ve patients with ...
August 28, 2017 β Bristol-Myers Squibb Company and Pfizer Inc. announced results from an analysis of real-world data ...
August 18, 2017 β Medtronic plc announced a global randomized clinical trial that will evaluate one-month dual ...